||||||||| |---|---|---|---|---|---|---|---| ||**Trustees' Annual Report for the period**||||||| |**From **|Period start date|||**To**|Period end date||| ||01|01|2024||31|12|2024| Section A Reference and administration details ASSOCIATION OF BIOMEDICAL ENGINEERS, MEDICAL **Charity name** ENGINEERS, AND BIOENGINEERS **Other names charity is known by** BioMedEng Association **Registered charity number (if any)** 1191005 **Charity's principal address** Department of Bioengineering, Imperial College London, Bessemer Building, London **Postcode** SW7 2AZ **Names of the charity trustees who manage the charity** |1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18|**Trustee name**|**Office (if any)**|**Dates acted if**
**not for whole**
**year**|**Name of person (or**
**body) entitled to**
**appoint trustee (if**
**any)**| |---|---|---|---|---| ||Prof Alicia El Haj|Universityof Birmingham||| ||Prof AnthonyBull|Imperial College London||| ||Prof Hazel Screen|Queen MaryUniversityof London||| ||Prof Vanessa Diaz|UniversityCollege London||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| ||**Names of the trustees for the charity, if any, (for example, any custodian trustees)**|||| ||**Name**||**Dates acted if not for whole year**|| |||||| |||||| |||||| March **2012** **TAR** 1 ## **Names and addresses of advisers (Optional information)** |**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**| |---|---|---| |**Type of adviser**
**Name**
**Address**||| |||| |||| |||| |||| |**Name of chief executive or names of senior staff members**||| Dr Gifty Tetteh – Head of Operations ## **Section B Structure, governance and management** ## **Description of the charity’s trusts** Charitable Incorporated Organisation Constitution Type of governing document (eg. trust deed, constitution) Association Model Constitution How the charity is constituted (eg. trust, association, company) Charity trustees are appointed by a resolution of the members at the Trustee selection methods annual general meeting. (eg. appointed by, elected by) **Co-opted Trustees** can also be appointed at any time by current trustees. - (eg. trust, association, company) ## **Additional governance issues (Optional information)** The BioMedEng Association Trustees’ Board for the 2024 reporting period You **may choose** to include comprised of the four Trustees (Profs Alicia El Haj, Anthony Bull, Hazel additional information, where Screen and Vanessa Diaz), the current Chair of Council (Prof Martin relevant, about: Knight, who will become a Co-opted Trustee at the end of the current • policies and procedures Chair of Council role in 2025) and the Head of Operations (Dr Gifty policies and procedures Tetteh). - policies and procedures adopted for the induction and training of trustees; Similar to the 2023 report, the Trustees’ Board is supported by the formal members of the Association, including the Chairs of the Working Groups (Education, Equality, Diversity and Inclusion, Early Career Researchers, Industry and Sponsorship, and Communications and Website) and the BioMedEng Council. - the charity’s organisational structure and any wider network with which the charity works; - relationship with any related parties; In addition to the formal members, the Association has established a wider affiliate membership provision. As detailed in our previous reports, the affiliate memberships are open to practising engineers, clinicians, students, and anyone who is interested in Biomedical Engineering, Medical Engineering and Bioengineering. - trustees’ consideration of major risks and the system and procedures to manage them. We welcome applications from UK and International members from Industry, Academic Institutions and Research Centres, Clinical Establishments and Hospitals, Governmental and Non-Governmental Organisations, amongst others. March **2012** **TAR** 2 **Section C Objectives and activities** **Summary of the objects of the charity set out in its governing document** Our charitable objects remain unchanged. The BioMedEng Association aims to advance education for the public benefit in biomedical engineering, medical engineering, and bioengineering, in particular but not exclusively by: 1. organising and holding scientific meetings and conferences; 2. and promoting the study and practice of biomedical engineering, medical engineering and bioengineering. The Association is a professional body for engineers, clinicians, researchers, and students working within Biomedical Engineering, Medical Engineering and Bioengineering disciplines. **BioMedEng24 Conference –** The 2024 annual conference of the Association, BioMedEng24, took place on 5[th] – 6[th] September at the Mile End Campus of Queen Mary, University of London (QMUL). The conference was hosted by Profs. Zion Tse (BioMedEng24 Chair), Hazel Screen, Martin Knight, Julia Shelton, Thomas Iskratsch, Julien Gautrot, and Dr. Azadeh Rezaei from the QMUL School of Engineering and Materials Science. The conference was opened by Prof. Andrew Livingston, the VicePrincipal of Research at QMUL. The packed BioMedEng24 programme included a plenary talk, and a newly introduced plenary debate session with 6 speakers, which was moderated by Prof Martin Knight from QMUL. **Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** The BioMedEng24 plenary talk on “ _New Bioengineered Materials for Advanced Therapeutics and Ultrasensitive Biosensing_ ” was delivered by Prof. Dame Molly Stevens from the University of Oxford. The plenary debate speakers included: - Prof. Anne Vanhoestenberghe and Dr Anna Barnes from King’s College London, - Prof Matthew Dalby from Glasgow University, - Ms Jane John-Lewis from Intuitive Medical, - Prof Alvaro Mata from the University of Nottingham and - Prof Hazel Screen from QMUL. March **2012** **TAR** 3 With over 400 abstract submissions to BioMedEng24, the conference programme included four (4) parallel keynote sessions which featured 26 keynote speakers, 1 dinner speaker (Prof. Karen Salt from UKRI), around 100 oral presentations, 300 posters, and 3 workshops (ECR, Women & Child Health Symposium, and Ansys Workshops). In addition to these, the conference hosted the BioMedEng Association AGM and the BioMedEng Council Meeting. BioMedEng24 was supported by three (3) Gold Sponsors, four (4) Silver Sponsors, and eight (8) Bronze Sponsors. Also, the RSPCA and Animal Free Research kindly sponsored a £1,000 award for the best presentation in support of animal replacement. March **2012** **TAR** 4 The conference was held in QMUL Mile End Campus, with the main sessions held in the Great Hall, People Palace, Engineering Building, Queen’s Building, Graduate Centre, and Geography Building. This arrangement allowed for optimal space allocation for the keynote, oral, and poster presentations whilst ensuring enough space for lunch and networking. With 170 dinner tickets sold, the dinner reception was well-received with an inspiring talk from Prof. Karen Salt from the UKRI, as the after-dinner speaker. The newly formed BioMedEng Band, made up of BioMedEng Association members delivered a spectacular performance, finishing the conference dinner on a high note. March **2012** **TAR** 5 In total, BioMedEng24 welcomed over 430 attendees from 51 universities over Europe and various industrial organisations. To ensure continuity between the BioMedEng conferences, Dr Gifty Tetteh, Head of Operations of the Association, met with the BioMedEng24 Chair on a monthly basis to address the team’s concerns, assist with newsletter communications, and abstract submission, delegate registrations, payment enquiries, website and conference administration, amongst others. They also met post conference to finalise the accounts and gather feedback and constructive suggestions for improving future conferences, whilst arranging for funds to be transferred in line with the proceeds split arrangements. More information about the BioMedEng24 conference is available at **https://biomedeng.org/biomedeng24** ## **Additional details of objectives and activities (Optional information)** You **may choose** to include further statements, where relevant, about: - policy on grantmaking; - policy programme related investment; - contribution made by volunteers. March **2012** **TAR** 6 Section D Achievements and performance ## **Summary of the main achievements of the charity during the year** **4[th] BioMedEng AGM –** The 2024 AGM of the BioMedEng Association took place at the BioMedEng24 Conference on 5[th] - 6[th] September 2024 in the Great Hall at QMUL. This year’s AGM was divided into two parts, the first part of the AGM (AGM A) held on 5[th] Sept 2024 focussed on presentations from the Working Group Chairs and the second part of the AGM (AGM B), held on 6[th] Sept 2024, was dedicated to operational updates from the Association. There were no elections at this year’s AGMs. Like previous years, the AGMs provided an opportunity for both formal and affiliate BioMedEng members to review activities of the Association, propose initiatives, and discuss important updates about the charity **.** ## **AGM A** The first part of the AGM was chaired by Prof Martin Knight, leader of the Working Group Chairs and Chair of Council for the BioMedEng Association. Updates from the Working Group Chairs are summarised below: **Early Career Researchers Working Group:** Currently chaired by Dr Rosti Readioff from the University of Liverpool, the ECR Working Group currently has 23 serving members who contribute to at least one of its three committees: communications, training and events, and mentoring committees. The working group has been meeting bi-monthly to track activities and plan for future directions. The communications committee of the ECR Working Group has been engaging with the ECR members of the Association through newsletters and social media content. Four newsletters were sent out to the ECR members, and a new dedicated ECR webpage: (www.biomedeng.org/ecr/) has been set up and promoted. The training and events committee for the ECR Working Group organised a panel discussion on ECR career paths during the BioMedEng24 conference at QMUL. The panel comprised individuals from startups, industry, and academia who shared their perspectives with ECR members of the Association. The committee is currently engaging with the Industry Working Group to develop training events between conferences with industry sponsors to extend the member's support throughout the year. The mentoring committee ran a mentoring scheme, manually pairing 21 mentor-mentees. The feedback on the first round of the mentoring scheme (January 2024 - October 2024) has been very positive, with some mentees requesting the freedom to select mentors. Due to a predicted increase in both the number of mentors and mentees and based on the mentees' feedback, an automated system was needed. The Association has therefore invested in developing a new webpage for the mentoring scheme within the dedicated ECR website. The new webpage for the mentoring scheme is currently under testing, and it is expected to be released to the BioMedEng members in January 2025. The plan for next year is to continue building on our existing activities and focus on increasing engagement and communication to provide tailored support to the Association's ECR members. March **2012** **TAR** 7 Section D Achievements and performance **Industry Working Group** : Chaired by Prof Mehran Moazen from University College London, the Industry WG priorities are to expand our sponsors/interaction with industry; plan future activities and ensure continuity of WG meetings and expand its membership. Considering these priorities, the main headlines for 2023-24 were: 1. to organised and run an online event on 14th June 2024 bringing together several industries and wider stakeholders to discuss industry-academia interactions, it is barriers, potential opportunities. Several interactions/activities were then started based on that event and work is ongoing to organise a similar event in 2025 that itself seems to be valuable for the BioMedEng community. 2. membership of the WG has grown with additional academic and industry members having joined the WG, enriching its discussion and interactions not only within the WG but also in terms of interacting with other WG i.e. Early Career and Education and supporting local organisers. **Education Working Group** : Chaired by Dr Anita Ghag from the University of Birmingham, the Education Working Group made good progress in 2024. They added a new member to the group, Manuela Trejo from Loughborough University and focussed on working on two main initiatives: 1. Lesson in a box type of activity which could be widely disseminated across secondary schools to increase awareness of biomedical engineering. They are currently finalising the activities to select the most engaging and resource appropriate ones. 2. EDI in education webinar in conjunction with the EDI working group. The team were working on this and aiming to host an event in spring 2025. **Equality, Diversity and Inclusions Working Group** – Chaired by Prof Gwen Reilly from the University of Sheffield, the EDI Working Group has eight core members, with membership drawn from volunteers within the BioMedEng community including senior Council members and early career researchers. The group aims to represent the host cities of our recent conference venues, different regions of the country and underrepresented groups. The main aims of the EDI working group are to 1. Understand barriers to inclusion within our BioMedEng society and related engineering fields. 2. Increase visibility, representation and progression of underrepresented groups in the BioMedEng community (collaboration with ECR team). 3. Support Biomedical Engineering research that is more inclusive in terms of both the end users needs and contributors to the design (collaboration with industry team) At the BioMedEng24 conference, the EDI Working Group hosted a parallel session titled ‘Inclusive engineering and technology’ to facilitate a discussion of EDI amongst BioMedEng members and showcase a diversity of biomedical engineering research. The chair also held a discussion about EDI issues and asked the members to comment on what they felt were the main barriers to creating a truly equal and diverse biomedical engineering programme. The most common responses related to funding, including the difficulty of funding March **2012** **TAR** 8 Section D Achievements and performance conference attendance and overall inequities in research funding. The second most frequent response concerned childcare and other commitments that prevents travel and working away. This discussion was followed by a variety of talks on ‘enabling’ technologies such as restoration of eye function, turban wearing and its risks/benefits during a bicycle accident, and melanin effects in oximetry measurements. There was also a presentation about an initiative at Herriot Watt University funded by the Royal Academy of Edinburgh to roll out some recommendations on inclusive design in biomechanics research projects. The EDI Working Group’s focus for 2025 is soliciting and identifying abstracts which demonstrate an inclusive engineering approach, at the BioMedEng25 conference. They are also planning to award a prize for the abstract that demonstrates inclusivity and diversity in the work presented. Also, they plan to facilitate training on how to embed inclusivity into the study design when writing grant proposals. This will be particularly important to early career researchers in the BioMedEng Association. ## **AGM B** The second part of the AGM was chaired by Prof Anthony Bull, Chair of Trustees of the BioMedEng Association. Similar to last year’s arrangement, the Association held a separate Council meeting prior to the 4[th] AGM, to review the action items from the 3[rd ] AGM and discuss key strategic Association initiatives prior to the 4[th] AGM. **Trustee Elections:** The Chair reminded members that there will be no Trustee elections in this AGM, as the board has decided to wait and appoint a new Chair of Council when the current Chair of Council becomes a Trustee in January 2026, before holding further Trustee elections, to allow members to stand for either Chair of Council or Trustee positions, if interested. **2024 BioMedEng Special Awards -** The 2024 Innovation Award was presented to Prof Yan Yan Shery Huang from the University of Cambridge, whilst the 2024 Legacy Award was presented to Prof David Firmin from Imperial College London. Both presentations were made at the BioMedEng24 conference dinner. Like previous years, the **BioMedEng Legacy Prize** was awarded to a UK Bioengineer/ Biomedical Engineer/ Medical Engineer whose career-long research and mentoring has contributed immensely to inspiring and training the next generation of academics, researchers, and students in the discipline. Similarly, the **BioMedEng Innovation Prize** was awarded to a UK Bioengineer/ Biomedical Engineer /Medical Engineer whose imaginative and ground-breaking work has opened up new fields in the discipline and/or led to new technologies that support medical interventions. **Operational Update -** Dr Gifty Tetteh, presented the Association’s operational update for 2023 at the Association’s 4[th] AGM. This focussed on the Charity Objects, Committee Changes, Membership Updates, Finance and Sustainability, and a reminder of the nomination process for the BioMedEng Special Awards. As previously mentioned, the Association’s charitable objects remain March **2012** **TAR** 9 Section D Achievements and performance unchanged. **Committee Changes:** Another round of Council elections was held in February 2024 as seven Council positions expired in December 2023. One of these members decided not to stand for re-election, three stood for re-election and another has moved abroad. The BioMedEng25 Chair - Dr Philip Riches, was invited to join Council and elections were held for new nominees and previous candidates in February 2024. In total, eight members joined to serve Council on a three-year term until December 2026, including Prof Ashraf Khir - Durham University, Dr Asimina (Melina) Kazakidi - Uni. of Strathclyde, Prof Yalin Zheng - Uni. of Liverpool, Dr Daniel Abasolo - University of Surrey, Prof Perumal Nithiarasu - Swansea University, Prof Amy Zavatsky - University of Oxford, Prof Sotiris Korossis - Loughborough Uni and Dr Philip Riches - University of Strathclyde. **Membership Growth:** There has been an increase of over 350 membership applications to the Association since the 2023 report. The membership update at the 2[nd] AGM in 2022, showed an increase from 490 applications from 64 institutions in Sept 2021, to 734 applications from 96 institutions in Sept 2022. Whilst the 2023 report outlined the details of 1,055 application from 131 Institutions. The membership breakdown at the 4[th] AGM detailed 1,406 applications from 171 Institutions, with 761 paid memberships, comprising of 407 Full Members, 352 PhD and MRes Students and 2 Retired/Emeritus. The remaining 645 free memberships were for UG and MSc memberships. Like previous years, GT highlighted key institutions with more than 10 BioMedEng members and those that have made significant gains over the 2023 – 2024 report period. A list of the 2023 and 2024 BioMedEng membership breakdown by institutions are included below. March **2012** **TAR** 10 Section D Achievements and performance **Affiliate Memberships –** The Association membership rates remain unchanged. The membership rates for the 2024 reporting year were £50/year for Full members, £20/year* for Research Student Members (PhD, MPhil and MRes), £75 for 5 years for Retired/Emeritus Members, and free annual memberships to verified undergraduate and MSc students. As detailed in our previous reports, the Association’s membership is open to practising engineers, clinicians, students, and anyone who is interested in Biomedical Engineering, Medical Engineering and Bioengineering. We welcome applications from UK and International members from Industry, Academic Institutions and Research Centres, Clinical Establishments and Hospitals, Governmental and NonGovernmental Organisations, amongst others. **Finance and Sustainability:** GT also discussed the details of the 2023 Independently Examined Accounts at the 4[th] AGM. This showed an income and expenditure of £73,412 and £ 77,665, respectively. The high expenditure for the 2023 reporting period resulted from the delayed payments of the UCL conference expenses at £57,387.05 and host institution contributions for 2021 at £5,952.00 and 2022 at £10,000.00, which were paid out and captured in the 2023 reports. With a 2022 balance B/F of £93,858.01, the 2023 B/F was £ 89,605.15 with liabilities of £59,508.85, comprising of the Swansea-BioMedEng23 conference payments at £40,908.85, BioMedEng23 Best Poster, talk etc conference award payments at £600, and the 2023 Host Institution Contribution at £18k. This will leave the Association with an overall balance of £30,096.3 for 2023, (£20,518.96 for 2022) after the 2023 liabilities have been paid out. March **2012** **TAR** 11 **Section E Financial review** The BioMedEng23 conference at Swansea had a total income and **Brief statement of the** expenditure of £101,586.61 and £64,608.85, respectively. This left a **charity’s policy on reserves** surplus of £36,977.76, which was generously shared with the Association. The organisers at Swansea University kept £10,000 of the conference proceeds and donated £26,977.76 to the Association. The Trustees acknowledged the significant contribution from Swansea and thanked the Conference Co-Chairs and team, for their generous donation to the Association. The actual closing balances, after all liabilities have been paid for the 2021, 2022 and 2023 financial years were £11,952, £20,518.96, and £30,096.3, respectively. The 2024 accounts have been independently examined with a copy attached to this report. As of 31 December 2024, the closing balance for the Association stood at £135,468.23. However, at this time, the Association has received most of the conference income and QMUL incurred most of the expense. This is to be reconciled early in 2025, but initial figures indicate that there is an overall conference profit of around £47,289.17 and QMUL will generously donate 75% of this to the Association. Please see the attached independently examined accounts for further details on the Association’s financial position. **Details of any funds materially in deficit** No funds are in deficit ## **Further financial review details (Optional information)** You **may choose** to include additional information, where relevant about: As detailed in the independently examined 2024 accounts attached, the Association’s core income is generated from membership dues and proceeds from hosting dedicated events and the annual conference. - the charity’s principal sources of funds (including any fundraising); - how expenditure has supported the key objectives of the charity; - investment policy and objectives including any ethical investment policy adopted. March **2012** **TAR** 12 **Section F Other optional information** ## **Section G Declaration** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s)** _GAJTetteh_ **Full name(s)** Dr Gifty Tetteh **Position (eg Secretary, Chair,** Head of Operations **etc) Date** 31.12.24 March **2012** **TAR** 13 CHARITY COMMISSION FOR ENGLAND AND WALES Independent examinerfs port on the accounts Section A Independent Examiner's Report Report to th• truste members of ASSOCIATION OF BIOIAEDICAL ENGINEERS, PAEDICAL ENGINEERS AND BIOENGINEERS On accounts for the year 3111212024 Charity no (If any) 1191005 Set out on pays I report to the trustees on my examination of the accounts of the above chanty (Ihe Trusf) for the year ended Responslbllltl•s and As the charity trustees of the Trust. you are responsible for the preparation basls of report of the accounts in acc<)rdm ¥￿th the rg]uirements of the Charities A 2011 ("the Acr). I report in resFe(* of my examination of the Trust's accounts carried out under sedion 145 of the 2011 Act and in carryiNJ out my examination, I have followed the applicable Directions gpien by the Chanty Commission under sedion 145(5)(b) of the A I have comF4eted my examination. I confirm that no material matters have come to rny attention (other than that disclosed below") in connection with the examination vthid) gprfes me cause to believe that in, any material Independent examinerfs 8tatsment accounting records were not k8Pt in accordance wlth 8ection 130 of the Act or the accounts do not a￿(*d *ith the accounting records I have no a)rK￿ and have come acyoss no other matters in conne(*ion with the examInat￿n to vhlth attents'on should drawn in order to enab￿ a proper understanding of the accounts to be reached. . Rease delete the words in the brnckets irthey do not 8ppty. 2810712025 Slgnod: Charles Osei, Bsc (Hons), Msc. FCIE. AF& ATA MCIPP Relevant professional quallficalionls) or body Ilf any): Associthn of Charty Ir￿rKIen￿ Examiners Addre8•: Flat 3, 11 ROChda￿ Way Deptford London SE8 4LY Section B Disclosure Only complete rf the examiner needs to hwhI￿ht matt8rs of concem {see CC32, Independent examinaknon of chanty accounts. directions and guidan￿ for examiners). Give hero brief detsils of any items that the examiner wishes to disGlose. ASSOCIATION OF BIOMEOICAL ENGINEERS, MEDICAL ENGINEERS AND BIOENGINEERS Receipts and payments accounts 11911)05 CC16a Forthe pèriod 01101r2024 3111212024 Section A Receipts and payments fund¥ Total funds Last year to tho r￿al￿ E toth2 n￿rE*£ tho nearesEE iothB nB7r4st£ to thg n8argst£ A1 Re¢ei Members, subsc Indust Event conferen￿ Fees Shèffiakl ConferencLe Fees Other lions 5,330 11YJ.615 100,615 88.075 Sub total(Gross income forAR) A2 As8gt and Investment gal•s. Is•• tabl•l. 110.IJ65 110.065 73,412 Sub totsl 110.065 110.065 73.412 A3Pa Refunds Processing Fees BioMedEn 24E nses Web8rte Expenses- ECR Membership ents 867 1.820 92 539 1.167 1,820 92 1.520 83 1,520 83 1,481 83 Video Hosting BioMedEng22 Conferencè Ch•rs Grfls 91 BiWedEng23 Costs and Charges- Swansea Uni BioM8dEn 23 Conference Awards BioMedEng22 Costs and Charges- UCL 2023 Host InstitulK)n ContrilxJtW- 57.387 18.(KKI 10.1)00 2021 Host In¥titul%Jn ContrikxdKTr 5,9$2 Operational- AccOmmodatic￿ aThJ Intemet Inde ndent Examination BioMedEn 23S l Awards erah"onal- Travel erats"onal- Condolences st81iona and Poslin 350 162 102 7T 19 Sub total 64,203 64.203 A4 As￿1 and InveBlment purcha8 180¢ tablg Sub total 03 Net of￿elp￿(paYrnentsj A5 Trdnsfers between funds A6 Ca9￿ fund# Llst y•ar8nd Cash funds this yearend .857 89.604 135.466 135.466 Section B Statement of assets and liabilities at the end of the period iJnYegtrl¢tsd Restricted fund¥ funds r*aTOSt£ Endowmènt fund8 to near•8te C•tegories Details B1 Ca8h funds 135.466 135,466 5)} R85trictod funds to nB7re5t£ Endo*rynent funth funds Details to nearest£ 82 Oth•r monetary 486ets Cgstlopkna CuThentV41u• Detai15 B3 Investmont as86ts Currwtvalu Details B4 Assots retain¢d for the charity's own uso FuThltowNch When duo Details BS Liabiliti Sigred by one ortsv tr￿18￿ ￿ t•hair all the tnjstees Date of roval Signature Professor Hazel Screen 25107125 2710712025 ASSOCIATION OF BIOMEDICAL ENGINEERS. MEDICAL ENGINEERS AND BIOENGINEERS R•gistsred Charity No. 1191005 FINANCIAL ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2024 CONTENTS Pagg Legal and Administrative Independent Examiner report Receipts and Payments Accounts Statement of Assets and Liabilities ASSOCIATION OF BIOMEDICAL ENGINEERS. MEDICAL ENGINEERS AND BIOENGINEERS Regist•rgd Charity No. 1191005 ORGANISATIONAL PROFILE R THE YEAR ENDED 31 DECEMBER 2024 TRUSTEES Prof Alhia El Haj Prof Anthony Bull Prof Hazel Screen REGISTERED OFFICE: The B￿MedEn9 Associab"on Department of Bioengineenng Imperial College London Bessemer Buihjing London UK SV47 2AZ ACCOUNTANTS: Chatles Osei, Bsc IHons}. MSC. FCIE. AFA, ATA, MCIPP Flat 3, 11 Rochdale Way London SE8 4LY CHARITY COMMISSION FOR ENGLAND AND WALES Independent examinerfs report on the accounts Section A Independent Examiner's Report Report to the trusteesl members of ASSOCIATION OF BIOMEDICAL ENGINEERS, MEDICAL ENGINEERS AND BIOENGINEERS On accounts for the year ended 3111212024 Charity no lif any) 1191005 Set out on pages I report to the trustees on my examination of the accounts of the above thartty (Ihe Trusf) for the year endéd Responsibilities and the chanty trustees of the Trust, you are responsible for the preparation basis of rep¢)rt of the accounts in accordan￿ with the rg]uirements of the Charities Act 2011 (Ihe Acr). I report in respect of my examinab.on of the Trust's accounts carried out under sedion 145 of the 2011 Act and in carying out rny examination, I have followed the applicable Directions given by the Charty Commission under sec*on 145(5){b) of the ACL I have compteted my examination. I confimi that no material matters have come to rny attention (other than that disclosed below") in connection with the examination vthich gNes me cause to believe that in, any material Independent examinerfs sLgtement accounting records were not kept in accordance with section 130 of the Act or the accounts do not &cord with the accounting reGords I have no concems and have come across no other matters in connection wtth the examination to which attention should be drawn in order to enable proper understanding of the accounts to be reached. ' Please delete the worfs in the brackets rfthey do not apply. 2810712025 Signed: Name: Charles Osei. Bsc (Hons). MSC, FCIE. AFA, ATA, MCIPP R818vant professional qualIf￿ation{s) or l)ody (if anyl: Association of Charrty Independence Examiners Address: Flat 3, 11 RoGhdale Way Deptford London SE8 4LY Section B Disclosure Only complete rf the examiner needs to hvJhlight matters of concem (se8 CC32, Independent examination of charty accounts.. directions and guidance for examiners). Give here brief details of any items that the examiner wishes to disclose. ASSOCIATION OF BIOMEOICAL ENGINEERS, MEDICAL ENGINEERS AND BIOENGINEERS Receipts and payments accounts 11911)05 CC16a Forthe pèriod 01101r2024 3111212024 Section A Receipts and payments fund¥ Total funds Last year to tho r￿al￿ E toth2 n￿rE*£ tho nearesEE iothB nB7r4st£ to thg n8argst£ A1 Re¢ei Members, subsc Indust Event conferen￿ Fees Shèffiakl ConferencLe Fees Other lions 5,330 11YJ.615 100,615 88.075 Sub total(Gross income forAR) A2 As8gt and Investment gal•s. Is•• tabl•l. 110.IJ65 110.065 73,412 Sub totsl 110.065 110.065 73.412 A3Pa Refunds Processing Fees BioMedEn 24E nses Web8rte Expenses- ECR Membership ents 867 1.820 92 539 1.167 1,820 92 1.520 83 1,520 83 1,481 83 Video Hosting BioMedEng22 Conferencè Ch•rs Grfls 91 BiWedEng23 Costs and Charges- Swansea Uni BioM8dEn 23 Conference Awards BioMedEng22 Costs and Charges- UCL 2023 Host InstitulK)n ContrilxJtW- 57.387 18.(KKI 10.1)00 2021 Host In¥titul%Jn ContrikxdKTr 5,9$2 Operational- AccOmmodatic￿ aThJ Intemet Inde ndent Examination BioMedEn 23S l Awards erah"onal- Travel erats"onal- Condolences st81iona and Poslin 350 162 102 7T 19 Sub total 64,203 64.203 A4 As￿1 and InveBlment purcha8 180¢ tablg Sub total 03 Net of￿elp￿(paYrnentsj A5 Trdnsfers between funds A6 Ca9￿ fund# Llst y•ar8nd Cash funds this yearend .857 89.604 135.466 135.466 Section B Statement of assets and liabilities at the end of the period iJnYegtrl¢tsd Restricted fund¥ funds r*aTOSt£ Endowmènt fund8 to near•8te C•tegories Details B1 Ca8h funds 135.466 135,466 5)} R85trictod funds to nB7re5t£ Endo*rynent funth funds Details to nearest£ 82 Oth•r monetary 486ets Cgstlopkna CuThentV41u• Detai15 B3 Investmont as86ts Currwtvalu Details B4 Assots retain¢d for the charity's own uso FuThltowNch When duo Details BS Liabiliti Sigred by one ortsv tr￿18￿ ￿ t•hair all the tnjstees Date of roval Signature Professor Hazel Screen 25107125 2710712025 llli llzi